🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ede
Clinical trial register · Netherlands

Clinical Trials in Ede, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3203 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:48 UTC
3203
Studies in scope
all four open statuses
1832
Recruiting now
open to new participants
608
Lead sponsors
across recruiting studies
Top sites
Amsterdam 1240 Rotterdam 867 Groningen 601 Nijmegen 559 Utrecht 541
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC4 Radboud University Medical Center4 Stichting Hemato-Oncologie voor Volwassenen Nederland4 Wageningen University4 AstraZeneca3
Site location
Amsterdam1240 Rotterdam867 Groningen601 Nijmegen559 Utrecht541
All 161 locations
Target enrolment
to

Trials with a site in Ede

51 of 3203 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Recruiting
The Effect of Muscle Stimulation and Amino Acid Intake on Protein Metabolism During Critical Illness
NCT07430969Muscle Wasting in Critically Ill
Wageningen University
Not applicable
30
Ede
2026-07-18
Recruiting
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
NCT07614984Lipoprotein(a)
DrugEnlicitide
Merck Sharp & Dohme LLC
Phase 2
750
Ede, Harderwijk, Roosendaal, Sneek, Dordrecht, Groningen
2026-06-30
Recruiting
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001Obesity, Heart Failure
DrugNNC0487-0111
Novo Nordisk A/S
Phase 3
5,610
's-Hertogenbosch, Amsterdam, Beverwijk, Breda, Dirksland, Ede, Eindhoven, Gouda
2026-05-11
Recruiting
The TASTY-training Study
NCT07258589Oncological Patients, Tyrosine Kinase Inhibitor
University Medical Center Groningen
Not applicable
90
Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda
2025-11-10
Recruiting
Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation
NCT07200466Endometrial Cancer
Radboud University Medical Center
Not applicable
735
Arnhem, Doetinchem, Ede, Nijmegen, Winterswijk, 's-Hertogenbosch, Breda, Eindhoven
2025-10-23
Recruiting
Long-Term Outcomes and Post-Intensive Care Syndrome: Investigating the Associations Between Metabolic Signatures and Physical Functioning in Critically Ill Patients
NCT07170527Post-Intensive Care Syndrome (PICS)
ARH van Zanten, MD PhD
Observational
200
Ede
2025-10-13
Recruiting
The Effect of Continuous Versus Intermittent Enteral Nutrition on Metabolic Outcomes in Critically Ill Patients
NCT07173504Critical Illness
Gelderse Vallei Hospital
Not applicable
124
Ede, Deventer, Enschede, Groningen, The Hague
2025-09-30
Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
NCT07181109High Risk Cardiovascular Disease, Hypertension, High Cardiovascular Risk
DrugZilebesiran
Alnylam Pharmaceuticals
Phase 3
11,000
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Doetinchem, Ede, Goes, Hoogeveen
2025-09-22
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Alkmaar, Almere Stad, Amersfoort, Amsterdam, Arnhem, Born, Ede, Hilversum
2025-09-02
Recruiting
Prospective Data Collection Initiative on Thoracic Malignancies
NCT06996249Lung Cancer, Thoracic Cancer, Lung Cancer, Nonsmall Cell, Adenocarcinoma
Dutch Society of Physicians for Pulmonology and Tuberculosis
Observational
12,000
Ede, Eindhoven, Hilversum, Utrecht, Alkmaar, Amersfoort, Amsterdam, Breda
2025-08-15
Recruiting
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
NCT06863272Castration-Resistant Prostatic Cancer, Metastasis
DrugsOpevesostat·Ifinatamab Deruxtecan·Abiraterone·Enzalutamide
Merck Sharp & Dohme LLC
Phase 1/2
360
Ede, Nijmegen, Drachten
2025-07-03
Recruiting
The TASTY-steering Study
NCT07258563Metastatic Triple Negative Breast Cancer, Metastatic Testicular Cancer, Stage II-IV Diffuse Large B Cell Lymphoma
University Medical Center Groningen
Not applicable
201
Amsterdam, Arnhem, Dirksland, Ede, Groningen, Nijmegen, Rotterdam, Scheemda
2025-06-06
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060Heart Failure
AstraZeneca
Phase 3
11,300
's-Hertogenbosch, Almelo, Amsterdam, Born, Deventer, Ede, Enschede, Haarlem
2025-03-14
Recruiting
Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease
NCT06871514Atherosclerotic Cardiovascular Diseases, Shared-decision Making
dr.Frank L.J. Visseren
Not applicable
1,200
Alkmaar, Amersfoort, Deventer, Ede, Nijmegen, The Hague, Utrecht
2025-02-18
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
NCT06627647Non-squamous Non-small Cell Lung Cancer
DrugsRilvegostomig·Pemetrexed·Keytruda·Cisplatin
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven
2024-11-27
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
NCT06692738Non-small Cell Lung Cancer
DrugsRilvegostomig·Nab-paclitaxel·Keytruda·Paclitaxel
AstraZeneca
Phase 3
1,160
Alkmaar, Ede, Groningen, Leidschendam, Veldhoven, Zwolle
2024-11-18
Recruiting
The Effect of a 2-week Preoperative Vegan Diet Versus Omnivorous Diet on the Protein Turnover in the Osteoarthritic Knee
NCT06130956Osteo Arthritis Knee, Protein Synthesis
Wageningen University
Not applicable
40
Arnhem, Ede
2024-10-22
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
's-Hertogenbosch, Apeldoorn, Ede, Enschede, Nijmegen
2024-10-03
Recruiting
Screening for Malnutrition in Obese Patients
NCT06626360Overweight and Obese Adults, Malnutrition or Risk of Malnutrition
HAN University of Applied Sciences
Observational
2,000
Amsterdam, Ede, Rotterdam
2024-10-02
Recruiting
Rehabilitation After a Hip Fracture: the Effects of Dietary Protein and Exercise on Bone and Muscle Health and Quality of Life
NCT07036341Hip Fractures
Wageningen University
Not applicable
102
Arnhem, Ede
2024-09-01
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
NCT06345729Non-small Cell Lung Cancer
DrugsCalderasib·Keytruda·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
600
Ede, Harderwijk, Zwolle, Utrecht
2024-05-24
Recruiting
Nutritional Care After Discharge in Children Term Born-18years Old
NCT06414200Malnutrition, Child
Erasmus Medical Center
Not applicable
260
Rotterdam, Alkmaar, Breda, Dordrecht, Ede, Eindhoven
2024-04-23
Recruiting
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLL
NCT05791409CLL/SLL
DrugsEpcoritamab·Venetoclax
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 1/2
112
's-Hertogenbosch, Alkmaar, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Groningen
2024-04-10
Recruiting
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492Stage III Non-small Cell Lung Cancer
Radboud University Medical Center
Not applicable
690
Hilversum, Amsterdam, Apeldoorn & Zutphen, Breda, Deventer, Ede, Eindhoven & Veldhoven, Emmen
2024-03-19
Active, closed
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
DrugLepodisiran
Eli Lilly and Company
Phase 3
17,300
Amersfoort, Amsterdam, Apeldoorn, Beverwijk, Delft, Deventer, Doetinchem, Ede
2024-03-05
Recruiting
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm
NCT05779631Bladder Cancer, Muscle-invasive Bladder Cancer
Radboud University Medical Center
Not applicable
360
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Boxmeer, Ede, Emmen
2023-12-06
Active, closed
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756Arteriosclerosis, Hypercholesterolaemia
DrugsEnlicitide Decanoate·Enlicitide
Merck Sharp & Dohme LLC
Phase 3
14,550
Emmen, Hoogeveen, Apeldoorn, Doetinchem, Ede, Harderwijk, Nijmegen, Tiel
2023-10-09
Recruiting
Effect of Collagen/Vitamin C in Jumper's Knee; a RCT
NCT05407194Patellar Tendinopathy
Gelderse Vallei Hospital
Not applicable
76
Ede
2023-04-01
Active, closed
MAD Trial: Myopia Atropine Dose
NCT05667454Progressive Myopia
Erasmus Medical Center
Phase 3
550
Almere Stad, Amsterdam, Delft, Deventer, Dordrecht, Ede, Goes, Heerenveen
2022-12-19
Active, closed
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351Severe Hypertriglyceridemia
DrugOlezarsen
Ionis Pharmaceuticals, Inc.
Phase 3
885
Amsterdam, Apeldoorn, Arnhem, Dirksland, Ede, Hoogeveen, Nijmegen, Rotterdam
2022-12-13
Active, closed
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
NCT05502237Non-small Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Nab-paclitaxel·Pemetrexed
Gilead Sciences
Phase 3
1,021
Breda, Ede, Groningen, Harderwijk, Tilburg
2022-10-12
Recruiting
Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design
NCT05200351Emotion Regulation, Autism Spectrum Disorder, Adolescent - Emotional Problem
Karakter Kinder- en Jeugdpsychiatrie
Not applicable
35
Ede, Heerjansdam, Mill
2022-02-14
Active, closed
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
NCT05202509Atherosclerotic Cardiovascular Disease
DrugObicetrapib
NewAmsterdam Pharma
Phase 3
9,541
Amsterdam, Arnhem, Beverwijk, Delft, Dirksland, Dordrecht, Ede, Eindhoven
2022-02-07
Active, closed
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)
NCT04597671Carcinoma, Non-Small-Cell Lung
DrugDurvalumab
Association NVALT Studies
Phase 3
170
Almelo, Amsterdam, Arnhem, Ede, Eindhoven, Flushing, Groningen, Maastricht
2021-12-06
Active, closed
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism, Deep Vein Thrombosis
Leiden University Medical Center
Not applicable
608
Leiden, Amsterdam, Assen, Beverwijk, Breda, Deventer, Drachten, Ede
2021-06-18
Active, closed
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
NCT04825743ST-elevation Myocardial Infarction (STEMI)
CeleCor Therapeutics
Phase 3
2,463
Heerlen, 's-Hertogenbosch, Amsterdam, Arnhem, Blaricum, Breda, Doetinchem, Ede
2021-04-24
Active, closed
Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04579367Hypercholesterolemia, Mixed Dyslipidemia
DrugBempedoic acid
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede, Eindhoven
2021-01-15
Active, closed
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
NCT04639362CLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Almere Stad, Amersfoort, Amsterdam, Dordrecht, Ede, Eindhoven, Enschede, Gouda
2020-12-29
Recruiting
REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
NCT04523428CLL/SLL
DrugsVenclyxto·Venclexta
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
60
's-Hertogenbosch, Amsterdam, Arnhem, Breda, Delft, Dordrecht, Ede, Eindhoven
2020-12-23
Recruiting
Prospective Bladder Cancer Infrastructure (ProBCI)
NCT04503577Bladder Cancer
Prospective Bladder Cancer Infrastructure Foundation
Observational
3,600
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Breda, Dordrecht, Ede
2020-10-04
Recruiting
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA
NCT04183426Abdominal Aortic Aneurysm, Cardiovascular Events
Rijnstate Hospital
Observational
194
Nijmegen, Apeldoorn, Deventer, Ede, Enschede, Veldhoven
2020-06-12
Active, closed
Natural Course of Pain Following Surgery Through an Abdominal Incision
NCT04088838Adhesions Abdominal, Adhesions Pelvic, Surgery Induced Tissue Adhesions, Chronic Pain
Radboud University Medical Center
Observational
650
Boxmeer, Nijmegen, Maastricht, Arnhem, Doetinchem, Ede
2020-01-01
Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
NCT03860883Cutaneous Melanoma, Stage II
Melanoma and Skin Cancer Trials Limited
Not applicable
2,998
Almere Stad, Ede, Zutphen, Eindhoven, Groningen, Heerlen, Maastricht, Utrecht
2019-12-17
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393Stroke, Atrial Fibrillation
DrugsNon-Vitamin K Anticoagulant·NOAC·Dabigatran·Edoxaban
Population Health Research Institute
Phase 4
2,270
's-Hertogenbosch, Alkmaar, Almelo, Amstelveen, Arnhem, Breda, Deventer, Ede
2019-06-14
Active, closed
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
NCT03463057NHL, DLBCL
DrugsTecentriq·Atezolizumab
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
109
's-Hertogenbosch, Amersfoort, Amsterdam, Apeldoorn, Breda, Delft, Dordrecht, Ede
2018-08-30
Active, closed
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
NCT02284308NSCLC
Maastricht Radiation Oncology
Observational
180
Almelo, Apeldoorn, Arnhem, Deventer, Ede, Eindhoven, Enschede, Gorinchem
2016-07
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Community-acquired Pneumonia, Influenza, COVID-19
DrugsConvalescent plasma·Repagermanium·Ivermectin·Amoxicillin-clavulanate
UMC Utrecht
Phase 3
20,000
's-Hertogenbosch, Almelo, Amersfoort, Amsterdam, Arnhem, Deventer, Ede, Eindhoven
2016-04-11
Recruiting
Future Optimal Research and Care Evaluation
NCT03823547Acute Coronary Syndrome, Myocardial Infarction
J.M. ten Berg
Observational
99,999
Apeldoorn, Arnhem, Ede, Tiel
2015-01-01
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugEnzalutamide
Pfizer
Phase 3
1,068
Amsterdam, Ede, Eindhoven, Groningen, Leeuwarden, Maastricht, Sneek
2014-12-17
Active, closed
The COLON Study: Colorectal Cancer Cohort
NCT03191110Colorectal Neoplasms Malignant
Wageningen University
Observational
2,000
Almelo, Apeldoorn, Arnhem, Doetinchem, Ede, Goes/Vlissingen, Groningen, Nijmegen
2010-08-03
Active, closed
Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer
NCT01057069Breast Cancer
DrugsDoxorubicin/cyclophosphamide·Carboplatin and Paclitaxel·Paclitaxel·Carboplatin
The Netherlands Cancer Institute
Phase 2/3
310
Alkmaar, Amsterdam, Delft, Deventer, Dordrecht, Ede, Haarlem, Heerlen
2010-01
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-netherlands/city/ede

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,203 studies in total at the last sync on 26 Sep 2026, 19:48 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Ede.

How many clinical trials are recruiting in Ede?

34 of the 51 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:48 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ede), 51 studies
PhaseStudiesRecruitingShare
Phase 317833.3%
Not applicable151429.4%
Observational10619.6%
Phase 2539.8%
Phase 1/2223.9%
Phase 2/3102%
Phase 4112%

Most active sponsors

Lead sponsors with the most studies (Ede)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC43
Radboud University Medical Center43
Stichting Hemato-Oncologie voor Volwassenen Nederland42
Wageningen University43
AstraZeneca33
Eli Lilly and Company21
Erasmus Medical Center21
Gelderse Vallei Hospital22
University Medical Center Groningen22
Alnylam Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.